Filtros de búsqueda

Lista de obras de Per Soelberg Sørensen

A Placebo-Controlled, Double-Blind, Cross-Over Trial of Flunarizine in Common Migraine

article by Per Soelberg Sørensen et al published March 1986 in Cephalalgia

A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod

artículo científico publicado en 2016

A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis

article

A new millennium? perhaps. A new european journal of Neurology? certainly!

scientific article published on 01 January 2000

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis

artículo científico publicado en 2010

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

artículo científico publicado en 2014

A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis

artículo científico publicado en 2006

A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

artículo científico publicado en 2015

A systematic review of the incidence and prevalence of cancer in multiple sclerosis

artículo científico publicado en 2014

A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis

artículo científico publicado en 2014

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview

artículo científico publicado en 2015

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis

artículo científico publicado en 2014

Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity

artículo científico publicado en 2009

Absence of hydrocephalus in spite of impaired cerebrospinal fluid absorption and severe intracranial hypertension

artículo científico publicado en 1987

Acute Respiratory Tract Infections and Mannose-Binding Lectin Insufficiency During Early Childhood

artículo científico publicado en 2001

Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655.

artículo científico publicado en 2011

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

artículo científico publicado en 2013

Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis

scientific article published on 01 March 2020

Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort

artículo científico publicado en 2013

Antibodies to IFN-beta: the Danish National IFN-beta Project

artículo científico publicado en 2003

Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate

artículo científico publicado en 2000

Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

artículo científico publicado en 2005

Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?

scientific article published on 09 February 2007

Assessment of CSF dynamics and venous flow in the superior sagittal sinus by MRI in idiopathic intracranial hypertension: a preliminary study.

artículo científico publicado en 1994

Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans

artículo científico publicado en 2012

Association between age at onset of multiple sclerosis and vitamin D level-related factors

artículo científico publicado en 2015

Association between an interleukin-13 promoter polymorphism and atopy.

artículo científico publicado en 2003

Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP

artículo científico publicado en 2008

Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis ⬇️

artículo científico publicado el 1 de diciembre de 2011

Bone lesions in early syphilis detected by bone scintigraphy ⬇️

artículo científico publicado el 1 de agosto de 1984

Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic response

artículo científico publicado en 2010

CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis

artículo científico publicado en 2005

CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis

artículo científico publicado en 2006

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

artículo científico publicado en 2012

CSF-amine metabolites in depression, dementia and in controls

scientific article published on 01 June 1987

Can we spot the IFNbeta nonresponders?

artículo científico publicado en 2008

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

artículo científico publicado en 2012

Central motor conduction as a measure of disease progression in early multiple sclerosis

artículo científico publicado en 1995

Cerebral blood flow in patients with normal-pressure hydrocephalus before and after shunting

article

Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study

artículo científico publicado en 2012

Cerebrospinal fluid bombesin and calcitonin in patients with central nervous system metastases from small-cell lung cancer.

artículo científico publicado en 1986

Cerebrospinal fluid flow and production in patients with normal pressure hydrocephalus studied by MRI

scientific article published on 01 April 1994

Cerebrospinal fluid vasopressin and increased intracranial pressure.

artículo científico publicado en 1984

Cerebrospinal fluid vasopressin as a marker of central nervous system metastases from small-cell bronchogenic carcinoma

artículo científico publicado en 1985

Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis

artículo científico publicado en 2012

Chronic comorbidity in multiple sclerosis is associated with lower incomes and dissolved intimate relationships.

artículo científico publicado en 2017

Cladribine tablets for relapsing-remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study

artículo científico publicado en 2011

Clinical course and prognosis of pseudotumor cerebri. A prospective study of 24 patients ⬇️

artículo científico publicado el 1 de febrero de 1988

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

artículo científico publicado en 2003

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

artículo científico publicado en 2017

Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab

artículo científico publicado en 2013

Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue

artículo científico publicado en 2011

Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study

artículo científico publicado en 2006

Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality

artículo científico publicado en 2017

Comparison of myelography combined with postmyelographic spinal CT and MRI in suspected metastatic disease of the spinal canal

artículo científico publicado el 1 de julio de 1992

Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs

artículo científico publicado en 2004

Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study

artículo científico publicado en 2000

Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression

artículo científico publicado en 2013

Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.

artículo científico publicado en 2012

Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis

artículo científico publicado en 2006

CorticalN-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients

artículo científico publicado en 2016

Deaths and disability from natalizumab are no longer tolerable: No – (they can be avoided) ⬇️

artículo científico publicado el 1 de agosto de 2012

Defining active progressive multiple sclerosis

artículo científico publicado en 2017

Defining the clinical course of multiple sclerosis: the 2013 revisions

artículo científico publicado en 2014

Demyelination versus remyelination in progressive multiple sclerosis.

artículo científico publicado en 2010

Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis

artículo científico publicado en 2012

Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study

artículo científico publicado en 2018

Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta

artículo científico publicado en 2016

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

artículo científico publicado en 2017

Differential microRNA expression in blood in multiple sclerosis.

artículo científico publicado en 2013

Disability in progressive MS is associated with T2 lesion changes

artículo científico publicado en 2017

Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?

artículo científico

Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E).

artículo científico publicado en 2002

Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.

artículo científico publicado en 2006

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

artículo científico publicado en 2018

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

artículo científico publicado en 2018

EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses

artículo científico publicado en 2005

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases

artículo científico publicado en 2008

EFNS guidelines on diagnosis and management of neuromyelitis optica

artículo científico publicado en 2010

Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.

artículo científico publicado en 2013

Early safety and efficacy of fingolimod treatment in Denmark.

artículo científico publicado en 2016

Early versus later treatment start in multiple sclerosis: a register-based cohort study

artículo científico publicado en 2018

Early-stage multiple sclerosis : what are the treatment options?

artículo científico publicado en 2004

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

artículo científico publicado en 2001

Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial

scientific article published on 01 January 1994

Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis

artículo científico publicado en 2012

Effects of fingolimod in relapsing-remitting multiple sclerosis

scientific article published on 28 March 2014

Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis

artículo científico publicado en 2009

Effects of neutralizing antibodies to interferon beta in multiple sclerosis: a logical paradox ⬇️

artículo científico publicado el 1 de febrero de 2012

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

artículo científico publicado en 2018

Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study

artículo científico publicado en 2009

Electroconvulsive therapy: a comparison of seizure duration as monitored with electroencephalograph and electromyograph

scientific article published on 01 September 1981

Employment, disability pension and income for children with parental multiple sclerosis

artículo científico publicado en 2016

Endogenous and recombinant type I interferons and disease activity in multiple sclerosis

scientific article (publication date: 2012)

Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis.

artículo científico publicado en 2015

Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

artículo científico publicado en 2017

Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels.

artículo científico publicado en 1981

Evolving concepts in the treatment of relapsing multiple sclerosis

artículo científico publicado en 2016

Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis

artículo científico publicado en 2012

FOXP3, CBLBandITCHgene expression and cytotoxic T lymphocyte antigen 4 expression on CD4+CD25high T cells in multiple sclerosis ⬇️

artículo científico publicado el 1 de noviembre de 2012

Familial effects on the clinical course of multiple sclerosis

artículo científico publicado en 2007

Fatal neurogenic pulmonary edema in a patient with progressive multiple sclerosis.

artículo científico publicado en 2008

Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability

artículo científico publicado en 1991

FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS

scientific article published on 16 February 2014

Gender and autoimmune comorbidity in multiple sclerosis

artículo científico publicado en 2014

Gender effects on treatment response to interferon-beta in multiple sclerosis.

artículo científico publicado en 2014

Gene expression analysis of interferon-beta treatment in multiple sclerosis

artículo científico publicado en 2008

Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis

artículo científico publicado en 2013

Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.

artículo científico publicado en 2004

Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

artículo científico publicado en 2011

Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis

artículo científico publicado en 2010

Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis

artículo científico publicado en 2011

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis

artículo científico publicado en 2005

Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO.

artículo científico publicado en 2016

Health-related quality of life in secondary progressive multiple sclerosis

artículo científico publicado en 2007

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

artículo científico publicado en 2016

How effective is natalizumab as second-line treatment for multiple sclerosis in daily clinical praxis?

artículo científico publicado en 2009

IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS.

artículo científico publicado en 2004

IVIG enters the central nervous system during treatment of experimental autoimmune encephalomyelitis and is localised to inflammatory lesions

artículo científico publicado en 2006

Immunogenicity and tolerability of an investigational formulation of interferon-β1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis

article

Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis.

artículo científico publicado en 2014

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

artículo científico publicado en 2015

Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression

artículo científico publicado en 2008

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.

artículo científico publicado en 2009

Intracerebral haemorrhage after carotid endarterectomy

article

Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri)

Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis

artículo científico publicado en 2002

Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis

artículo científico publicado en 1998

Intravenous immunoglobulin G therapy: effects of acute and chronic treatment in multiple sclerosis.

artículo científico publicado en 1996

Intravenous immunoglobulin ameliorates experimental autoimmune encephalomyelitis and reduces neuropathological abnormalities when administered prophylactically

scientific article published on 01 September 2005

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial

artículo científico publicado en 2008

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial

artículo científico publicado en 2004

Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis

artículo científico publicado en 2005

Intravenous polyclonal human immunoglobulins in multiple sclerosis

scientific article published on January 2008

Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort

artículo científico publicado en 2016

Is History of Squamous-Cell Skin Cancer a Marker of Poor Prognosis in Patients with Cancer?

scientific article published on 01 November 1999

Is the treatment effect of IFN-beta restored after the disappearance of neutralizing antibodies?

artículo científico publicado en 2008

Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO Trials

artículo científico publicado en 2017

Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q

artículo científico publicado en 2000

Linkage analysis suggests a region of importance for multiple sclerosis in 3p14-13

scientific article published on 01 December 2001

Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis

scientific article published on 01 October 1999

Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study

artículo científico publicado en 2018

Low cerebrospinal fluid concentration of brain-specific protein D2 in patients with normal pressure hydrocephalus.

artículo científico publicado en 1983

Low frequency and rare coding variation contributes to multiple sclerosis risk

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study

artículo científico publicado en 2012

MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS)

artículo científico publicado en 2005

MRI to monitor treatment efficacy in multiple sclerosis

artículo científico publicado en 2007

Management of patients with neutralizing antibodies against interferon-beta: stop IFN-beta therapy or wait for the antibodies to go away?

artículo científico publicado en 2009

Measuring and evaluating interferon beta-induced antibodies in patients with multiple sclerosis

artículo científico publicado en 2006

Metastatic epidural spinal cord compression. Results of treatment and survival.

artículo científico publicado en 1990

Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression.

artículo científico publicado en 1990

Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon-β.

artículo científico publicado en 2009

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

artículo científico publicado en 2010

Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.

artículo científico publicado en 2016

Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage Agents

artículo científico publicado en 2017

Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis

Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis

Multi-slice echo-planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis

artículo científico publicado en 2005

Multiple Sclerosis After Infectious Mononucleosis

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

artículo científico publicado en 2005

Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1.

artículo científico publicado en 2009

Multiple sclerosis impairs regional functional connectivity in the cerebellum

artículo científico publicado en 2013

Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies

artículo científico publicado en 2016

Multiple sclerosis. Generic glatiramer acetate--a step toward cheaper MS drugs?

artículo científico publicado en 2015

Multiple sclerosis: pathophysiology revisited

artículo científico publicado en 2005

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.

artículo científico publicado en 2009

Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial

artículo científico publicado en 2014

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

artículo científico publicado en 2011

Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis

artículo científico publicado en 2016

Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report

artículo científico publicado en 2007

Neutralizing antibodies against interferon-β do not predispose antibodies against natalizumab

artículo científico publicado en 2011

Neutralizing antibodies hamper IFNbeta bioactivity and treatment effect on MRI in patients with MS.

artículo científico publicado en 2006

Neutralizing antibodies to disease-modifying agents in the treatment of multiple sclerosis

artículo científico publicado en 2004

New management algorithms in multiple sclerosis

artículo científico

No linkage or association of the nitric oxide synthase genes to multiple sclerosis

scientific article published on 01 September 2001

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

artículo científico publicado en 2016

Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab

scientific article published on 20 April 2011

Oral fumarate for relapsing-remitting multiple sclerosis.

artículo científico publicado en 2008

Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis

artículo científico publicado en 2010

Ozanimod: a better or just another S1P receptor modulator?

artículo científico publicado en 2016

PLASMA PYRIDOSTIGMINE LEVELS IN MYASTHENIA GRAVIS

Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis

scientific article published on 01 June 2006

Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper

artículo científico publicado en 2016

Physical and social environment and the risk of multiple sclerosis

artículo científico publicado en 2014

Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: a randomized single-masked cross-over pilot study

scientific article published on 01 June 1996

Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients.

artículo científico publicado en 2010

Population-based study of acute respiratory infections in children, Greenland

scientific article published on June 2002

Prediction of antibody persistency from antibody titres to natalizumab

scientific article published on 27 March 2012

Prediction of response to interferon therapy in multiple sclerosis

scientific article published on 18 June 2014

Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study).

artículo científico

Principles of a new treatment algorithm in multiple sclerosis

artículo científico publicado en 2011

Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis

artículo científico publicado en 2013

Prospective evaluation of the effect on initial brain metastases from small cell lung cancer of platinum-etoposide based induction chemotherapy followed by an alternating multidrug regimen

artículo científico publicado en 1993

Pulsed immune reconstitution therapy in multiple sclerosis

REGARD: what can we learn from randomised, open-label, head-to-head studies?

scientific article published on 11 September 2008

Radiologic features compared to clinical findings in a prospective study of 153 patients with metastatic spinal cord compression treated by radiotherapy

artículo científico publicado en 1997

Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

artículo científico publicado en 2007

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

artículo científico publicado en 2010

Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis

artículo científico publicado en 2015

Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

artículo científico publicado en 2014

Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis : Analysis of Economic Data from the CLARITY Study

artículo científico publicado en 2012

Remyelination is extensive in a subset of multiple sclerosis patients.

artículo científico publicado en 2006

Reply

Reporting clinical trials: full access to all the data

Reproduction and the risk of multiple sclerosis

artículo científico publicado en 2013

Resource allocation to brain research in Europe

artículo científico publicado en 2007

Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale

artículo científico publicado en 2005

Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis

artículo científico publicado en 2013

Review: Neutralizing antibodies against interferon-beta ⬇️

artículo científico publicado el 1 de septiembre de 2008

Risk factors for acute respiratory tract infections in young Greenlandic children

artículo científico publicado en 2003

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

artículo científico publicado en 2012

Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

artículo científico publicado en 2017

Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study

artículo científico publicado en 2014

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study

Second occurrence of symptomatic metastatic spinal cord compression and findings of multiple spinal epidural metastases

artículo científico publicado en 1995

Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivity

artículo científico publicado en 2014

Segmenting Multiple Sclerosis Lesions Using a Spatially Constrained K-Nearest Neighbour Approach

article by Mark Lyksborg et al published 2012 in Lecture Notes in Computer Science

Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis

artículo científico publicado en 2015

Significantly increased fractions of transformed to total alpha2-macroglobulin concentrations in plasma from patients with multiple sclerosis

artículo científico publicado en 2004

Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.

artículo científico publicado en 2011

Smoking affects the interferon beta treatment response in multiple sclerosis

artículo científico publicado en 2018

Smoking and oral contraceptives as risk factors for cervical carcinoma In situ

Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis

article published in 2018

Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosis

artículo científico publicado en 2016

Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis

artículo científico publicado en 2017

Stroke incidence and risk factors for stroke in Copenhagen, Denmark.

artículo científico publicado en 1988

Studies of vasopressin in the human cerebrospinal fluid.

artículo científico publicado en 1986

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study

artículo científico publicado en 2018

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

artículo científico publicado en 2011

Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients

scientific article published on 01 January 1994

Syphilitic normal pressure hydrocephalus

artículo científico publicado el 1 de enero de 1979

Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression

artículo científico publicado en 2013

The Danish Multiple Sclerosis Treatment Register

artículo científico publicado en 2016

The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis. The Danish Multiple Sclerosis Group

artículo científico publicado en 2000

The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility

scholarly article published 13 July 2017

The SH2D2A gene and susceptibility to multiple sclerosis

artículo científico publicado en 2008

The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis.

artículo científico publicado en 2001

The changing demographic pattern of multiple sclerosis epidemiology

scientific article published on May 2010

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis

artículo científico publicado en 2013

The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis

artículo científico publicado en 2009

The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis

artículo científico publicado en 2008

The efficacy of multidisciplinary rehabilitation in stable multiple sclerosis patients

artículo científico publicado en 2006

The gap between effect of drugs and effectiveness of treatments

artículo científico publicado en 2007

The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review

artículo científico publicado en 2014

The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review

artículo científico publicado en 2015

The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects

artículo científico publicado en 2016

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

artículo científico publicado en 2009

The relationship between MRI and PET changes and cognitive disturbances in MS.

artículo científico publicado en 2006

The role of intravenous immunoglobulin in the treatment of multiple sclerosis

artículo científico publicado en 2003

The six spot step test: a new measurement for walking ability in multiple sclerosis

artículo científico publicado en 2006

Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations

artículo científico publicado en 2005

Therapeutic interference with leukocyte recirculation in multiple sclerosis.

artículo científico publicado en 2015

Tract-oriented statistical group comparison of diffusion in sheet-like white matter

Transient ischaemic attacks in young patients: a thromboembolic or migrainous manifestation? A 10 year follow up study of 46 patients.

artículo científico publicado en 1990

Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy

scientific article published on 04 December 2018

Treatment of Hookworm Anemia ⬇️

artículo científico publicado el 1 de enero de 1971

Treatment of multiple sclerosis with IVIg: potential effects and methodology of clinical trials

artículo científico publicado en 1994

Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.

artículo científico publicado en 2003

Treatment of multiple sclerosis--now and in future. The Danish Multiple Sclerosis Society and the Danish Multiple Sclerosis Group

artículo científico publicado en 2007

Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis

artículo científico publicado en 2008

Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect

artículo científico publicado en 2015

Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients

artículo científico publicado en 2003

Using measurements of neutralizing antibodies: the challenge of IFN-beta therapy

artículo científico publicado en 2007

Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a

artículo científico publicado en 2003

Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark

artículo científico publicado en 2016

Vasopressin release during electroconvulsive therapy

scientific article published on 01 January 1982

Visual evoked potentials in pseudotumor cerebri

scientific article published on 01 February 1985

Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab

artículo científico publicado en 2016

Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?

artículo científico

Widespread demyelination in the cerebellar cortex in multiple sclerosis.

artículo científico publicado en 2007

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda